THE RAF 'PARADOX BREAKER' INHIBITOR, PLX8394, ACTIVATES ERK1/2 IN ENDOTHELIAL CELLS AND PROMOTES CARDIAC REMODELLING

被引：0
|
作者：
Cooper, Susanna [1 ]
Cull, Josh [2 ]
Clerk, Angela [2 ]
Meijles, Daniel [1 ]
机构：
[1] St Georges Univ London, London, England
[2] Univ Reading, Reading, Berks, England
来源：
HEART | 2021年 / 107卷
关键词：
D O I：
10.1136/heartjnl-2021-BCS.231
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
BS33
引用
收藏
页码：A174 / A174
页数：1
相关论文
共 50 条
  • [1] RAF 'PARADOX BREAKER' PLX8394 ACTIVATES ERK1/2 VIA CRAF, WITH NO EFFECT ON ANGII-INDUCED CARDIAC REMODELLING IN MICE
    Cooper, Susanna
    Haines, Zoe
    Meijles, Daniel
    HEART, 2022, 108 : A148 - A148
  • [2] RAF 'Paradox Breaker' Inhibitor, PLX8394, Enhances Inflammation And Apoptosis In Murine Hypertension In Vivo
    Cooper, Susanna T.
    Malone, Giles O.
    Haines, Zoe H.
    Meijles, Daniel N.
    CIRCULATION RESEARCH, 2022, 131
  • [3] PLX8394, a RAF inhibitor, inhibits enterovirus 71 replication by blocking RAF/MEK/ERK signaling
    Wu, Chengyuan
    Zhu, Guangyan
    Qiu, Fang
    Ren, Fuli
    Lin, Binbin
    Zhang, Dingyu
    Yang, Qingyu
    Huang, Chaolin
    VIROLOGICA SINICA, 2023, 38 (02) : 276 - 284
  • [4] Activity, safety and circulating tumour DNA (ctDNA) dynamics of paradox breaker BRAF inhibitor PLX8394 in patients with advanced cancer
    Gouda, M. A.
    Sherman, E. J.
    Gilcrease, G. W.
    Vaishampayan, U. N.
    Parikh, A.
    Feun, L.
    Kummar, S.
    Huang, H.
    Zhang, C.
    Severson, P.
    Inokuchi, K.
    Silverman, M.
    Bollag, G.
    Janku, F.
    ANNALS OF ONCOLOGY, 2020, 31 : S465 - S465
  • [5] Angiogenin activates Erk1/2 in human umbilical vein endothelial cells
    Liu, SM
    Yu, DH
    Xu, ZP
    Riordan, JF
    Hu, GF
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2001, 287 (01) : 305 - 310
  • [6] BRAF paradox breakers PLX8394, PLX7904 are more effective against BRAFV600E CRC cells compared with the BRAF inhibitor PLX4720 and shown by detailed pathway analysis
    Koumaki, Kassandra
    Kontogianni, Georgia
    Kosmidou, Vivian
    Pahitsa, Fani
    Kritsi, Eftichia
    Zervou, Maria
    Chatziioannou, Aristotelis
    Souliotis, Vassilis L.
    Papadodima, Olga
    Pintzas, Alexander
    BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2021, 1867 (04):
  • [7] Simulated ischemia activates ERK1 and ERK2 in flow-adapted endothelial cells
    Wei, ZH
    Al-Mehdi, AB
    Fisher, AB
    FASEB JOURNAL, 2000, 14 (04): : A200 - A200
  • [8] Simulated ischemia activates Erk1 and Erk2 in flow-adapted endothelial cells
    Wei, ZH
    Al-Mehdi, AB
    Fisher, AB
    JOURNAL OF INVESTIGATIVE MEDICINE, 2000, 48 (02) : 204A - 204A
  • [9] Cardiac hypertrophy: Targeting Raf/MEK/ERK1/2-signaling
    Lorenz, Kristina
    Schmitt, Joachim P.
    Vidal, Marie
    Lohse, Martin J.
    INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2009, 41 (12): : 2351 - 2355
  • [10] Hyperactivation of MEK–ERK1/2 signaling and resistance to apoptosis induced by the oncogenic B-RAF inhibitor, PLX4720, in mutant N-RAS melanoma cells
    F M Kaplan
    Y Shao
    M M Mayberry
    A E Aplin
    Oncogene, 2011, 30 : 366 - 371
12345